Femtech Worid

3 weeks ago | femtechworld.co.uk | Sarah Sinclair

After building one of the world’s biggest women’s health apps—and selling it to one of the world’s biggest tech companies— Amber Vodegel thought about retiring and spending her days playing tennis. “I’ve definitely thought about slowing down, but I couldn’t walk away knowing how much still needs to change in women’s health,” she tells Femtech World. “Tennis can wait.”Vodegel began building Pregnancy+ in 2012 as a side-hustle, while continuing in her day job at an advertising agency.

1 month ago | femtechworld.co.uk | Sarah Sinclair

In March, six leading startups in the femtech space filed formal complaints with the European Commission over systemic bias and discrimination in content moderation by major online platforms. Led by advocacy campaign CensHERship and blended-finance investment portfolio The Case For Her, the start-ups are invoking the Digital Services Act (DSA) to expose how platforms disproportionately restrict, shadow ban and remove health-related content aimed at women.

1 month ago | femtechworld.co.uk | Sarah Sinclair

Every three seconds, someone in the world develops dementia, with women at significantly greater risk. Statistics show that two out of three Alzheimer’s patients are women, as are four out of five of those with multiple sclerosis, while women are three times more more likely to experience migraines and to be diagnosed with mental health issues such as depression and anxiety.

1 month ago | femtechworld.co.uk | Sarah Sinclair

Dr Ndidiamaka Amutah-Onukagha, the Julia A. Okoro Professor of Black Maternal Health at Tufts University School of Medicine, believes we are facing a “maternal health crisis”. Even with its vast resources, in the US, Black women are two to three times more likely to die during childbirth than their white peers. It’s no better in the UK, where maternal mortality for Black women is currently almost four times higher than for white women.

2 months ago | femtechworld.co.uk | Aron Solomon

For decades, Depo-Provera was marketed as a convenient, long-lasting birth control option for women who want to take control of their reproductive health without the hassle of daily pills. It was sold as a solution—an easy shot every three months that promised reliability and freedom.